PMC:7035340 / 3509-3646 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"94","span":{"begin":55,"end":59},"obj":"Gene"},{"id":"108","span":{"begin":18,"end":27},"obj":"Disease"}],"attributes":[{"id":"A94","pred":"tao:has_database_id","subj":"94","obj":"Gene:54726"},{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"More importantly, mortality benefit favored the severe HIN1-illness in the adjunctive treatment group with low dose of corticosteroids12."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":96,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"More importantly, mortality benefit favored the severe HIN1-illness in the adjunctive treatment group with low dose of corticosteroids12."}

{"project":"LitCovid-sentences","denotations":[{"id":"T20","span":{"begin":0,"end":137},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"More importantly, mortality benefit favored the severe HIN1-illness in the adjunctive treatment group with low dose of corticosteroids12."}

{"project":"2_test","denotations":[{"id":"32296012-28464462-139944477","span":{"begin":134,"end":136},"obj":"28464462"}],"text":"More importantly, mortality benefit favored the severe HIN1-illness in the adjunctive treatment group with low dose of corticosteroids12."}